Close Menu

NEW YORK (GenomeWeb) – Cambridge Isotope Laboratories and MRM Proteomics said yesterday that they have signed an exclusive global supply agreement for mass spec-based targeted proteomics assays.

Under the agreement, CIL will have exclusive selling rights to MRM Proteomics' PeptiQuant kits used for quantitative proteomics and will provide distribution for the products worldwide.

The most widely used mass spec approach for targeted protein quantitation, MRM-MS assays typically incorporate stable isotope labeled (SIL) peptides to improve their accuracy and reproducibility.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.